The Valley Desk

NCT03398148 · Interventional trial

A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Overall registry status Completed

Phase 2 · Phase 3

Conditions Ulcerative Colitis (UC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov